Due to their ability to pass through the BBB, EVs can be potential markers for GBM Our study found elevated levels of LDHA-enriched EVs in the plasma with GBM relapse, associated with glycolysis, poor chemotherapeutic response, and shorter survival of patients. Here, LDHA is linked to glioblastoma.